Literature DB >> 21293325

Vital signs: prevalence, treatment, and control of hypertension--United States, 1999-2002 and 2005-2008.

.   

Abstract

BACKGROUND: Hypertension is a modifiable risk factor for cardiovascular disease. It affects one in three adults in the United States and contributes to one out of every seven deaths and nearly half of all cardiovascular disease-related deaths in the United States.
METHODS: CDC analyzed data from the National Health and Nutrition Examination Survey (NHANES) on the prevalence, treatment, and control of hypertension among U.S. adults aged ≥18 years. Hypertension was defined as an average blood pressure ≥140/90 mmHg or the current use of blood pressure-lowering medication. Control of hypertension was reported as an average treated systolic/diastolic blood pressure <140/90 mmHg. Multivariate analysis was performed to assess changes in prevalence of hypertension, use of pharmacologic treatment, and control of blood pressure between the 1999-2002 and 2005-2008 survey cycles.
RESULTS: During 2005-2008, approximately 68 million (31%) U.S. adults aged ≥18 years had hypertension, and this prevalence has shown no improvement in the past decade. Of these adults, 48 million (70%) were receiving pharmacologic treatment and 31 million (46%) had their condition controlled. Although 86% of adults with uncontrolled blood pressure had medical insurance, the prevalence of blood pressure control among adults with hypertension was especially low among participants who did not have a usual source of medical care (12%), received medical care less than twice in the previous year (21%), or did not have health insurance (29%). Control prevalence also was low among young adults (31%) and Mexican Americans (37%). Although the prevalence of hypertension did not change from 1999-2002 to 2005-2008, significant increases were observed in the prevalence of treatment and control.
CONCLUSIONS: Hypertension affects millions of persons in the United States, and less than half of those with hypertension have their condition controlled. Prevalence of treatment and control are even lower among persons who do not have a usual source of medical care, those who are not receiving regular medical care, and those who do not have health insurance. IMPLICATIONS FOR PUBLIC HEALTH PRACTICE: To improve blood pressure control in the United States, a comprehensive approach is needed that involves policy and system changes to improve health-care access, quality of preventive care, and patient adherence to treatment. Nearly 90% of persons with uncontrolled hypertension have health insurance, indicating a need for health-care system improvements. Health-care system improvements, including use of electronic health records with registry and clinical decision support functions, could facilitate better treatment and follow-up management, and improve patient-physician interaction. Allied health professionals (e.g., nurses, dietitians, health educators and pharmacists) could help increase patient adherence to medications. Patient adoption of healthy behaviors could improve their blood pressure control. Reducing dietary intake of salt would greatly support prevention and control of hypertension; a 32% decrease in average daily consumption, from 3,400 mg to 2,300 mg, could reduce hypertension by as many as 11 million cases. Further reductions in sodium intake to 1,500 mg/day could reduce hypertension by 16.4 million cases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21293325

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  175 in total

1.  Gene panels to help identify subgroups at high and low risk of coronary heart disease among those randomized to antihypertensive treatment: the GenHAT study.

Authors:  Amy I Lynch; John H Eckfeldt; Barry R Davis; Charles E Ford; Eric Boerwinkle; Catherine Leiendecker-Foster; Donna K Arnett
Journal:  Pharmacogenet Genomics       Date:  2012-05       Impact factor: 2.089

2.  Effects of individual physician-level and practice-level financial incentives on hypertension care: a randomized trial.

Authors:  Laura A Petersen; Kate Simpson; Kenneth Pietz; Tracy H Urech; Sylvia J Hysong; Jochen Profit; Douglas A Conrad; R Adams Dudley; LeChauncy D Woodard
Journal:  JAMA       Date:  2013-09-11       Impact factor: 56.272

3.  Blood pressure and cholesterol control in hypertensive hypercholesterolemic patients: national health and nutrition examination surveys 1988-2010.

Authors:  Brent M Egan; Jiexiang Li; Suparna Qanungo; Tamara E Wolfman
Journal:  Circulation       Date:  2013-07-02       Impact factor: 29.690

4.  Multilevel and spatial-time trend analyses of the prevalence of hypertension in a large urban city in the USA.

Authors:  Longjian Liu; Ana E Núñez; Xiaoping Yu; Xiaoyan Yin; Howard J Eisen
Journal:  J Urban Health       Date:  2013-12       Impact factor: 3.671

5.  Assessing pharmacy students' ability to accurately measure blood pressure using a blood pressure simulator arm.

Authors:  Michelle M Bottenberg; Ginelle A Bryant; Sally L Haack; Andrew M North
Journal:  Am J Pharm Educ       Date:  2013-06-12       Impact factor: 2.047

6.  Recognition and Management of Elevated Blood Pressure in Pediatric Patients: Challenges and Disparities in Community Health Centers.

Authors:  Rikki L Ward; Jessica M Robbins; Rebecca N Haden; Brittany J Benson; Issy C Esangbedo
Journal:  J Community Health       Date:  2016-04

Review 7.  Team-based care and improved blood pressure control: a community guide systematic review.

Authors:  Krista K Proia; Anilkrishna B Thota; Gibril J Njie; Ramona K C Finnie; David P Hopkins; Qaiser Mukhtar; Nicolaas P Pronk; Donald Zeigler; Thomas E Kottke; Kimberly J Rask; Daniel T Lackland; Joy F Brooks; Lynne T Braun; Tonya Cooksey
Journal:  Am J Prev Med       Date:  2014-06-02       Impact factor: 5.043

8.  Systolic blood pressure response after high-intensity interval exercise is independently related to decreased small arterial elasticity in normotensive African American women.

Authors:  Stephen J Carter; TaShauna U Goldsby; Gordon Fisher; Eric P Plaisance; Barbara A Gower; Stephen P Glasser; Gary R Hunter
Journal:  Appl Physiol Nutr Metab       Date:  2016-01-07       Impact factor: 2.665

9.  Educational and Gender Differences in Health Behavior Changes After a Gateway Diagnosis.

Authors:  Elaine M Hernandez; Rachel Margolis; Robert A Hummer
Journal:  J Aging Health       Date:  2016-12-08

10.  A young patient with a family history of hypertension.

Authors:  Aldo J Peixoto
Journal:  Clin J Am Soc Nephrol       Date:  2014-08-04       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.